In 38 adults with obesity and poorly controlled asthma, 12 weeks of the mitochondrial antioxidant MitoQ 40 mg did not change methacholine airway reactivity versus placebo (median change 0.0 vs −0.8 μg, p=0.81), nor asthma control or quality of life.
RCTn = 38
Dixon et al. Mitochondrial antioxidant therapy fails to improve obese asthma outcomes